| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Harmony Biosciences Holdings Inc. | ZYN001 | Peripheral Neuropathic Pain (PNP) | Phase 2 | Trial Discontinued | Transdermal | Neurology |
| Harmony Biosciences Holdings Inc. | Zygel (ZYN002) - (BELIEVE 1) | Developmental and Epileptic Encephalopathies (DEE) | Phase 2 | Trial Discontinued | Transdermal | Neurology |
| Harmony Biosciences Holdings Inc. | Zygel (ZYN002) - (BRIGHT) | Autism Spectrum Disorder (ASD) | Phase 3 | Trial Discontinued | Transdermal | Psychiatric |
| Harmony Biosciences Holdings Inc. | ZYN002 - (CONNECT-FX) | Fragile X Syndrome in Children and Adolescents | Phase 3 | Ongoing | Transdermal | Genetic Disorder |
| Harmony Biosciences Holdings Inc. | Zygel (ZYN002) - STOP | Osteoarthritis | Phase 2 | Trial Discontinued | Transdermal | Orthopedic |
| Harmony Biosciences Holdings Inc. | WAKIX (pitolisant) - (TEMPO) | Excessive daytime sleepiness associated with Prader-Willi Syndrome (PWS) | Phase 3 | Ongoing | oral | Genetic Disorder |
| Harmony Biosciences Holdings Inc. | Zygel (ZYN002) | Adult Epilepsy Patients with Refractory Focal Seizures | Phase 2 | Trial Discontinued | Transdermal | Neurology |
| Harrow Inc Com | MELT-300 - (LOUISE) | Cataract | Phase 3 | Ongoing | oral | Opthalmic |